Debut Biotechnology, Inc., a L’Oreal SA-backed company that recently expanded its partnership with the beauty giant, launches BiotechXBeautyLabs, a development and contract manufacturing business that it says provides biotechnology access to companies that previously could not afford it.
Debut ‘Democratizes’ Biotech Product Formulation, Promising Superior Claims, Sustainability
San Diego-based Debut Biotechnology, Inc., which recently expanded an ingredient development partnership with L’Oréal SA, has launched BiotechXBeautyLabs development and contract manufacturing to make it possible for all brands – even those without expertise, proprietary ingredients or investment capability – to join the biotech revolution.
More from Innovation & IP
More from Ingredients & Safety
• By
Australian government finds an insufficient body of new evidence to support Rx-to-OTC switch of erectile dysfunction drug sildenafil since it was last considered in 2020.
• By
It is well established that antibiotics disrupt the human gut microbiome, but what is not so well established is the use of probiotics to restore it, find the authors of a recently published scientific literature review.
• By
UK food toxicity committee says substantial exceedances of the Acceptable Daily Intake of turmeric - such as through excessive supplement use - represents a potential health risk to humans.